Certara to Acquire Chemaxon, Expanding Biosimulation Capabilities in Drug Discovery

Certara, Inc.  a global leader in model-informed drug development, today announced it has signed a definitive agreement to acquire Chemaxon, a leadi...

July 10, 2024 | Wednesday | News
Apriori Bio Secures $1.1 Million from CEPI to Enhance AI-Driven Vaccine Platform Against Evolving Viruses

Biotechnology company Apriori Bio has been awarded US $1.1 million from CEPI to advance its biology-informed artificial intelligence platform Octavi...

July 09, 2024 | Tuesday | News
Eli Lilly to Acquire Morphic Holding for $3.2 Billion, Expanding Gastroenterology Portfolio

Eli Lilly and Company (NYSE: LLY) and Morphic Holding, Inc. (NASDAQ: MORF)  announced a definitive agreement for Lilly to acquire Mor...

July 09, 2024 | Tuesday | News
Roche's Vabysmo® Prefilled Syringe Gains FDA Approval for Major Eye Conditions

Roche  announced  that the United States Food and Drug Administration (US FDA) has approved the Vabysmo® (faricimab) 6.0 mg single-dose pre...

July 05, 2024 | Friday | News
Biogen Inc. Completes Acquisition of Human Immunology Biosciences (HI-Bio™)

Biogen Inc. has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology company foc...

July 03, 2024 | Wednesday | News
Samsung Bioepis Receives FDA Approval for PYZCHIVA® as Biosimilar to Stelara for Multiple Inflammatory Conditions

Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for PYZCHIVA&re...

July 01, 2024 | Monday | News
Nxera Pharma Hits Major R&D Milestone in Collaboration with AbbVie, Secures $10 Million Payment

Nxera Pharma  announces that it has reached an important R&D milestone under its multi-target discovery collaboration with AbbVie targeting neur...

June 27, 2024 | Thursday | News
Abzena and Argonaut Forge Strategic Partnership to Transform Biopharmaceutical Manufacturing

Abzena, the leading end-to-end integrated contract and development manufacturing organization (CDMO) for complex biologics and bioconjugates, andArgonaut...

June 24, 2024 | Monday | News
WACKER and CordenPharma Consortium Enters Pandemic Readiness State to Produce 80 Million Vaccine Doses Annually

    • Consortium formed between WACKER & CordenPharma has officially entered the pandemic readiness state as of 1 June 2024 to produ...

June 21, 2024 | Friday | News
AbbVie’s SKYRIZI® Gains FDA Approval for Moderate to Severe Ulcerative Colitis and Crohn's Disease Following Successful Phase 3 Trials

AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for adults with moderately to severely ac...

June 20, 2024 | Thursday | News
Alvotech and Advanz Pharma Partner to Commercialize Biosimilar Eylea® Candidates in Europe

  Alvotech  a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz P...

June 18, 2024 | Tuesday | News
AbbVie and FutureGen Announce Strategic Partnership to Develop Next-Generation IBD Therapy

AbbVie  and FutureGen Biopharmaceutical (Beijing) Co., Ltd. announced a license agreement to develop FG-M701, a next generation TL1A antibody for th...

June 14, 2024 | Friday | News
Pfizer Celebrates 175 Years of Innovation and Global Healthcare Leadership

Landmark event marks Pfizer's enduring legacy, innovative achievements and commitment to help shaping the future of global healthcare By leveraging AI...

June 12, 2024 | Wednesday | News
ChargePoint Technology Launches Innovative Robotic Material Handling Solution for Pharma Industry

ChargePoint Technology, a powder and liquid transfer specialist, has announced the launch of a new robotic material handling solution aimed at increasing s...

June 11, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close